Logo-jpe

Epidemiology and Prevention

1. Coronavirus disease 2019; epidemiology and recommendations
Mousa Ghelichi-Ghojogh* ORCID, Ehsan Allah Kalteh ORCID, Mohammad Fararooei ORCID
J Prev Epidemiol. 2020;5(1): e01. doi: 10.34172/jpe.2020.01
Article
PDF
XML
Cited By:
6

Epidemiology and Prevention

2. Possible ameliorative effect of colchicine on the prevention of cytokine storm and its associated hyper-inflammation in patients with COVID-19
Bijan Keikhaei ORCID, Mohammad Bahadoram* ORCID, Elham Rajaei ORCID, Kosar Alikhani ORCID, Ammar Helalinasab
J Prev Epidemiol. 2020;5(1): e02. doi: 10.34172/jpe.2020.02
Article
PDF
XML
Cited By:
2
Review

3. Confirmatory and supportive laboratory investigations in SARS-CoV-2 infection; a systematic review
Eranga Harshani Silva*, Sarath Lekamwasam
J Prev Epidemiol. 2020;5(1): e03. doi: 10.34172/jpe.2020.03
Article
PDF
XML
Cited By:
0
Original

4. Trend of case fatality rate during first 30 days of COVID-19 epidemic; the example of Iran
Khatereh Anbari ORCID, Seyyed Amir Yasin Ahmadi ORCID, Mitra Elmi* ORCID
J Prev Epidemiol. 2020;5(1): e05. doi: 10.34172/jpe.2020.05
Article
PDF
XML
Cited By:
1
Original

5. COVID-19 infection and beta thalassemia; a single center experience in Iran

Roya Salehi Kahyesh ORCID, Arash Alghasi* ORCID, Bijan Keikhaei Dehdezi ORCID, Adeleh Khazami ORCID, Marzeieh Abbasi Nasab ORCID
J Prev Epidemiol. 2021;6(2): e24. doi: 10.34172/jpe.2021.24
Article
PDF
XML
Cited By:
0

Mini Review

6. Long-term complications of COVID-19; an updated mini-review to the current knowledge

Fatemeh Shafieyeh* ORCID, Mahsa Heydari ORCID
J Prev Epidemiol. 2021;6(1): e14. doi: 10.34172/jpe.2021.14
Article
PDF
XML
Cited By:
0

Review

7. Prospective approach to manage COVID-19-related cytokine storm; an updated review on current concepts

Mohaddeseh Bahmani ORCID, Lillian Saberian* ORCID
J Prev Epidemiol. 2021;6(1): e20. doi: 10.34172/jpe.2021.20
Article
PDF
Suppl 1
XML
Cited By:
0

Review

8. COVID-19 in diabetic patients; impacts and implications
Mohaddeseh Bahmani ORCID, Rojin Chegini ORCID, Hamid Nasri* ORCID
J Prev Epidemiol. 2020;5(2): e29. doi: 10.34172/jpe.2020.29
Article
PDF
XML
Cited By:
0

Epidemiology and Prevention

9. Inhibiting inflammasome; the possible mechanisms of action of azithromycin against COVID-19?
Ali Saeedi-Boroujeni ORCID, Mohammad Bahadoram ORCID, Bijan Keikhaei, Mohammad-Reza Mahmoudian-Sani* ORCID, Azadeh Khayyat, Mohammad Ali Esmaeilpour
J Prev Epidemiol. 2021;6(1): e10. doi: 10.34172/jpe.2021.10
Article
PDF
XML
Cited By:
0

Original

10. COVID-19 and acute kidney injury presentation; stages and prognosis

Amirali Soheili ORCID, Sina Khani ORCID, Sadra Montazeri ORCID, Arash Shayegh ORCID, Misaagh Haji Miragha ORCID, Melika Sadat Jameie ORCID, Laya Jalilian Khave ORCID, Ghazal Sanadgol ORCID, Dorsa Shirini ORCID, Saba Ilkhani ORCID, Yasaman Sadat Keshmiri ORCID, Shahrzad Nematollahi ORCID, Maryam Karami ORCID, Elahe Taziki* ORCID
J Prev Epidemiol. 2021;6(1): e15. doi: 10.34172/jpe.2021.15
Article
PDF
XML
Cited By:
1

Review

11. Housing and urban design for COVID-19 pandemic; design for prevention of virus spread

Delaram Shahbazian* ORCID
J Prev Epidemiol. 2021;6(1): e02. doi: 10.34172/jpe.2021.02
Article
PDF
XML
Cited By:
1

Mini Review

12. Treatment of COVID-19 by CD24FC; a mini-review to the current knowledge
Ghazal Ghasempour Dabaghi ORCID, Mehrdad Rabiee Rad ORCID, Lillian Saberian* ORCID
J Prev Epidemiol. 2021;6(1): e04. doi: 10.34172/jpe.2021.04
Article
PDF
XML
Cited By:
1

Mini Review

13. Guidelines for the treatment of rheumatic patients in the pandemic of COVID-19 infection
Mansoor Karimifar* ORCID, Mozhgan Karimifar
J Prev Epidemiol. 2020;5(2): e30. doi: 10.34172/jpe.2020.30
Article
PDF
XML
Cited By:
0

Review

14. A review of the reasons for high prevalence and rapid progression of COVID-19 in men
Neda Taghizabet ORCID, Fatemeh Rezaei-Tazangi* ORCID, Hossein Roghani‐Shahraki ORCID
J Prev Epidemiol. 2022;7(1): e03. doi: 10.34172/jpe.2022.03
Article
PDF
XML
Cited By:
0
Epidemiology and Prevention

15. High mobility group box 1 (HMGB1) in COVID-19

Fatemeh Kafi ORCID, Alireza Bolourian, Zahra Mojtahedi ORCID, Alireza Pouramini* ORCID
J Prev Epidemiol. 2021;6(1): e11. doi: 10.34172/jpe.2021.11
Article
PDF
XML
Cited By:
4

Review

16. Role of Kaletra (combination of lopinavir and ritonavir) in the treatment of COVID-19 virus infection; an issue related to kidney transplant patients – A review study on current knowledge

Seyed Seifollah Beladi Mousavi ORCID, Fatemeh Hayati, Ehsan Valavi ORCID, Isa Rezaee ORCID, Shokouh Shayanpour ORCID, Leila Sabetnia* ORCID
J Prev Epidemiol. 2020;5(2): e28. doi: 10.34172/jpe.2020.28
Article
PDF
XML
Cited By:
0

Epidemiology and Prevention

17. In-center hemodialysis and COVID 19 infection
Seyed Seifollah Beladi Mousavi ORCID, Shahla Ahmadi Halili* ORCID, Asieh Aref ORCID
J Prev Epidemiol. 2020;5(2): e32. doi: 10.34172/jpe.2020.32
Article
PDF
XML
Cited By:
0

Review

18. The relationship between serum vitamin D level and COVID-19; a review study

Yasaman Koohshoori ORCID, Ehsan Ramanian, Nasrin Moradi, Shahrzad Shadabi, Minoo Motahhar, Masoumeh Sadat Mousavi*, Mahmood Banoore
J Prev Epidemiol. 2020;5(2): e34. doi: 10.34172/jpe.2020.34
Article
PDF
XML
Cited By:
0

Review

19. The relationship between COVID-19 and blood vitamin C; a systematic review study
Sadeq Hosseinpour ORCID, Nasrin Moradi, Reyhane Izadi, Shahrzad Shadabi, Raheleh Behzadi, Masoumeh Sadat Mousavi*, Abuzar Shirazi ORCID, Ebrahim Moayedi ORCID
J Prev Epidemiol. 2021;6(2): e31. doi: 10.34172/jpe.2021.31
Article
PDF
XML
Cited By:
0

Review

20. Possibility of the blood clot, thrombotic thrombocytopenia following injection of COVID-19-vaccine AstraZeneca; a systematic review

Mahnaz Momenzadeh ORCID, Ebrahim Moayedi ORCID, Seyedeh Leila Dehghani, Shahrzad Shadabi, Mohammad Moein Derakhshan Barjoei, Masoumeh Sadat Mousavi* ORCID, Samira Pourrezaei
J Prev Epidemiol. 2023;8(2): e34192. doi: 10.34172/jpe.2023.34192
Article
PDF
XML
Cited By:
0
Letter to Editor

21. Gender difference in response to COVID vaccination; a letter to the editor on current findings

Leila Alem ORCID, Hamid Nasri ORCID, Zahra Mojtahedi* ORCID
J Prev Epidemiol. 2023;8(2): e35206. doi: 10.34172/jpe.2023.35206
Article
PDF
XML
Cited By:
0
Mini Review

22. Collapsing glomerulopathy following COVID 19 infection; a mini-review to the recent data

Leila Alem ORCID, Maryam Farahmandsadr ORCID, Azadeh Khayyat ORCID, Mohammad Ali Esmaeil Pour ORCID, Hamid Nasri* ORCID
J Prev Epidemiol. 2023;8(2): e35223. doi: 10.34172/jpe.2023.35223
Article
PDF
XML
Cited By:
0
Review

23. What special precautions are required while anesthetizing COVID-19 patients in the operation room?

Nasrin Aghazade ORCID, Allahveirdy Arjmand ORCID, Mohammad Arabsorkhi ORCID, Vahid Rahmani* ORCID
J Prev Epidemiol. 2024;9(1): e35226. doi: 10.34172/jpe.2023.35226
Article
PDF
XML
Cited By:
Original

24. Acute kidney injury and COVID-19; incidence, risk factors, and mortality
Sholeh Tavakoly Shiraji ORCID, Milad Fooladgar ORCID, Aidin Shahilooy ORCID, Fatemeh Yassari ORCID, Nazila Bagheri ORCID, Maryam Abbasy ORCID, Sahar Tavakoli Shiraji* ORCID
J Prev Epidemiol. 2025;10(1): e38247. doi: 10.34172/jpe.2025.38247
Article
PDF
XML
Cited By:
Original

25. Evaluation of measles immunity in patients with COVID-19 infection in Isfahan
Morteza Pourahmad ORCID, Sara Nasirharandi, Mahnaz Momenzadeh* ORCID, Elahe Nasri, Shahzad Baradaran, Kiana Shahzamani, Fatemeh Nikoukar, Zahra Doozandeh, Ameneh Arab Chadegani
J Prev Epidemiol. 2025;. doi: 10.34172/jpe.2025.39259
Article
PDF
XML
Cited By: